Thus, dopamine levels induced by substance abuse could, at least in part, promote the development of neuroHIV by increasing HIV entry and also by interfering with CCR5-targeted antiretroviral therapies such as the CCR5 inhibitor, maraviroc. This evidence concerns the gene CCR5 and substance abuse.